大核心梗死取栓治疗天花板:超越ASPECTS的限制
该研究基于韩国全国多中心注册数据(2022-2024),比较定量梗死体积与ASPECTS在取栓患者中的预后价值。发现定量体积能更好区分预后,并识别出梗死体积>110 mL为取栓获益消失的治疗天花板,建议将体积阈值纳入患者筛选。
要点
- ASPECTS判为大核心但DWI体积未证实者,预后与双小核心组相当。
- DWI、CTP和NCCT均证实大核心者预后差,调整后OR为6.92。
- 取栓总体获益在梗死体积>110 mL时消失,提示治疗天花板。
核心结论
- 定量梗死体积比ASPECTS提供更好的预后区分能力,并识别出≥110 mL为取栓获益可忽略的治疗天花板。
研究设计与样本
- 基于韩国全国多中心注册研究(2022-2024),纳入552例接受取栓治疗的患者,平均年龄70.4±12.6岁,男性319例(57.8%)。
主要发现
- ASPECTS-only大核心组与双小核心组预后不良比例相当(11.8% vs 11.7%),调整后无额外风险。
- DWI-only大核心组调整后OR为6.92(95% CI 2.58-19.34),预示不良预后。
- 取栓总体获益减弱,common OR为0.56(95% CI 0.31-1.03)。
- 梗死体积50-110 mL区间取栓有获益(common OR 0.38,95% CI 0.15-0.97),>110 mL时获益消失。
关键数值与推荐
- 主要结局为90天mRS评分5-6分;靶试验模拟以90天mRS序贯移位为主要结局。
临床怎么用
- 建议将定量梗死体积阈值(尤其>110 mL)整合入取栓患者筛选,以减少无效再灌注并优先保障安全。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent trials established the efficacy of thrombectomy for large-core stroke by utilizing the Alberta Stroke Program Early Computed Tomography Score (ASPECTS) as a pragmatic tool. However, whether this topographical scoring captures the therapeutic ceiling, or the upper threshold of infarct volume where the benefit of reperfusion diminishes, remains unclear. METHODS: Leveraging a nationwide multicenter registry in Korea (2022-2024), we compared the prognostic value of quantitative volumetry and ASPECTS in thrombectomy-treated patients. We analyzed discordance between ASPECTS and volumetry derived from diffusion-weighted imaging, computed tomography perfusion, and noncontrast computed tomography. The primary outcome was poor functional outcome (90-day modified Rankin Scale score 5-6). To estimate treatment effects across specific volume spectra, we conducted target trial emulations that stratified causal estimates by volumetric thresholds, with the ordinal 90-day modified Rankin Scale score shift as the primary outcome. RESULTS: Among 552 patients, the mean age was 70.4±12.6 years, and 319 (57.8%) were men. Patients classified as large core by ASPECTS but not by diffusion-weighted imaging volumetry (ASPECTS-only large core) had poor outcome proportions comparable to the both small-core group (11.8% versus 11.7%), with no excess risk after adjustment. Conversely, volumetric confirmation of large core across diffusion-weighted imaging, computed tomography perfusion, and noncontrast computed tomography consistently predicted poor prognosis regardless of ASPECTS (adjusted odds ratio, 6.92 [95% CI, 2.58-19.34] for the diffusion-weighted imaging-only large-core group). In the target trial emulations, the overall benefit of thrombectomy was attenuated (common odds ratio, 0.56 [95% CI, 0.31-1.03]). Stratified analyses delineated a therapeutic ceiling, with benefit in the 50 to 110 mL range (common odds ratio, 0.38 [95% CI, 0.15-0.97]) disappearing in extensive infarctions >110 mL. CONCLUSIONS: Quantitative volumetry provided better prognostic discrimination and identified ≥110 mL as a therapeutic ceiling where the benefit of thrombectomy becomes negligible. These findings advocate integrating volumetric thresholds into patient selection to minimize futile reperfusion and prioritize safety, serving as a critical refinement to current topographical scoring.
引用
- Kim H, Ryu WS, Inoue M, et al. Defining the Therapeutic Ceiling of Endovascular Thrombectomy in Large-Core Stroke: Beyond the Limits of ASPECTS. Stroke. 2026. PMID: 42403349. doi:10.1161/STROKEAHA.126.055374
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。